14-day Premium Trial Subscription Sign Up For FreeGet Free

Weaker Stock
Today EXAS ranks #10237 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

EXACT Sciences Corporation Stock Forecast NASDAQ:EXAS

$76.13 (-1.67%)

Volume: 4M

Closed: Jan 19, 2022

Hollow Logo Score: -1.921

EXACT Sciences Corporation Stock Forecast

$76.13 (-1.67%)

Volume: 4M

Closed: Jan 19, 2022

Score Hollow Logo -1.921

EXACT Sciences Corporation Company Profile

441 Charmany Drive

Madison WI 53719



EXACT Sciences Corporation


Exact Sciences Corporation, a molecular diagnostics company, focuses on developing products for the early detection and prevention of various cancers. The company develops the Cologuard, a non-invasive stool-based DNA screening test for the early detection of colorectal cancer and pre-cancer. Its Cologuard test includes a protein marker to detect blood in the stool, utilizing an antibody-based fecal immunochemical test. The company has a collaboration, license, and purchase agreement with Genzyme Corporation, as well as with MAYO Foundation for Medical Education and Research for developing tests to detect lung, pancreatic, and esophageal cancers. Exact Sciences Corporation was founded in 1995 and is headquartered in Madison, Wisconsin.

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE